OPTmizing Advanced Stage HodgkIn LymphoMa patIentS Therapy

Clinical trial NCT03527628 · UNKNOWN

Trial details

NCT number: NCT03527628
Sponsor: King Abdullah International Medical Research Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Classical Hodgkin Lymphoma Hodgkin Lymphoma (Category)Hodgkin Disease Hodgkin Lymphoma

Start date: 2018-01-01
Primary completion: 2021-01-15
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.